Follicular lymphoma (FL) B cells contract tight connections with their microenvironment, which governs the pathogenesis and progression of the disease. Indeed, specific immune response gene signatures, obtained from whole biopsy samples, have been associated with patient survival. In this study, we performed gene expression profiling of purified B cell and non-B cell compartments obtained from FL and reactive lymph nodes. We identified 677 non-redundant genes defining the FL interface and involving 26 FL-specific functional networks. This approach highlighted an interleukin-4 (IL-4)-centered pathway associated with an activation of signal transducer and activator of transcription 6 (STAT6), which favors overexpression of IL-4-target genes. In addition, FL microenvironment was characterized by a strong enrichment in follicular helper T cells (T FH ), as demonstrated through transcriptomic and flow cytometry analyses. The majority of phospho-STAT6 pos B cells were located at the vicinity of cells expressing the programmed death 1 (PD-1) T FH marker. Moreover, purified FL-derived T FH , expressed IL4 at very high levels compared with purified tonsil-derived T FH or non-T FH microenvironment. Altogether, our study demonstrated that tumorinfiltrating T FH specifically express functional IL-4 in FL, creating an IL-4-dependent T FH -B cell axis. This cross talk could sustain FL pathogenesis and represent a new potential therapeutic target.
Introduction
Follicular lymphoma (FL) is the most common indolent nonHodgkin's lymphoma and remains virtually incurable. FL tumors arise from germinal center (GC) B cells and are characterized by the balanced chromosomal translocation t (14;18) , leading to the deregulation of BCL2 expression. 1 Occurring in about 85% of FL cases, this BCL2-JH translocation was also detected in a small proportion of circulating atypical B cells in healthy individuals, which represent potential premalignant intermediates of the FL pathogenesis. 2 Therefore, translocated BCL2 gene is not sufficient per se to drive FL development, thus predicting the existence of additional genetic and/or environmental factors crucial for lymphomagenesis and clinical behavior. Several studies argue for FL as a disease under the dependency of strong interactions between tumor B cells and their microenvironment. Both stromal cells and CD40 ligand signal efficiently promoted the survival of FL B cells in vitro. 3, 4 In addition, within invaded lymph nodes (LNs) and bone marrow, malignant B cells are observed admixed with specialized stromal cells, including follicular dendritic cells, and CD4 pos T cells, thus mimicking the normal GC organization. 1 Interestingly, CD4 pos T cells in the follicles, called follicular helper T cells (T FH ), were recently suggested to constitute a distinct lineage of T helper cells that arises independently of Th1, Th2 and Th17 effector subsets, and is required for normal B cell selection and differentiation into long-lived plasma cells. [5] [6] [7] However, no studies have addressed to date the role of T FH in FL pathogenesis. The cellular composition of the non-malignant infiltrate was described as related to FL prognosis but these studies have often generated conflicting results. High numbers of CD7 pos , CD4 pos , Foxp3 pos and PD-1 pos T cells were successively reported to predict a longer survival in FL patients. [8] [9] [10] [11] Moreover, the spatial distribution, rather than a numerical change, of non-malignant cells seems to be important, as a perifollicular location of Foxp3 pos T cells was associated with a better prognosis, 8 whereas FL with rapid transformation showed a predominantly intrafollicular CD4 pos pattern of expression. 12 However, these results remain controversial and a range of commonly used T-cell markers fail to identify a significant association with overall survival. 8, 13 Other studies reported that a reactive environment infiltrated by a low number of CD8 pos T cells 14 or a high content of CD68 pos or CD163 pos macrophages 9, 13 or mast cells 15 was associated with adverse clinicobiological manifestations and unfavorable outcome in FL patients that were treated with conventional chemotherapy. Of note, the predictive value of microenvironment cell populations in FL is highly dependent on specific treatment protocols. 16, 17 To draw a more complete picture of the influence of the microenvironment in FL, microarray analyses were performed and allowed to identify two specific molecular signatures associated with patient's outcome independently of classical clinical features. 18 One was associated with a favorable outcome and corresponded to T cell-and monocyte-restricted genes; whereas the other one involved genes expressed by activated macrophages and dendritic cells, and was associated with an adverse prognosis. Subsequent studies confirmed that the clinical behavior in FL is determined essentially by the gene expression profile of the microenvironment rather than by inherent properties of tumor cells themselves. 19, 20 However, the specific contribution of the non-malignant compartment has never been addressed in these retrospective studies.
To better understand the host-tumor interaction in FL, we performed comprehensive gene expression analyses on purified B cell and non-B cell compartments of tumor and reactive LN. This study enables to explore the molecular cross talk between tumor cells and tumor-infiltrating immune cells by identifying a specific list of genes involved in the FL interface. In this list, we identified an IL-4-centered pathway and demonstrated that T FH are expanded within invaded LN and are the major IL-4-producing cells in FL.
Patients and methods

Patients and samples
All tissues used for this study came from subjects recruited under institutional review board approval and informed consent process according to the Principles of the Declaration of Helsinki. Samples were obtained either from freshly isolated LN from 29 patients with de novo FL at diagnosis, and 11 patients with reactive non-malignant disease (NEG) considered as normal counterpart, or from 11 human tonsils (TONS) collected from children undergoing routine tonsillectomy. All FLs showed a predominantly follicular growth pattern, CD10 expression, and were classified into grades, 1, 2 or 3a, according to the World Health Organization diagnostic criteria. Patients with grade 3b FL or with disease in relapse after treatment, and transformed FL were excluded. Clinical characteristics of FL patients are listed in Supplementary Table S1 . Tissues were rapidly dissociated after collection and flushed using syringe and needle. Cell suspensions were then filtered and washed by centrifugation to obtain the unselected cell fraction.
Flow cytometry characterization of B and non-B subpopulations
Flow cytometry analyses of cell suspensions obtained after mechanically dissociation were performed on a Cytomics FC500 (Beckman Coulter, Miami, FL, USA) or a FACSAria (Becton Dickinson, Franklin Lakes, NJ, USA) flow cytometer using several cocktails of monoclonal antibodies (Supplementary Table S2 ). Percentages of tumor B cells among CD19 pos B cells were determined as CD19 pos cells with a restricted expression of k or l light chain after subtraction of the expected percentage of normal B cells expressing this isotype.
Cell sorting
Purification of B (CD19 pos ) and non-B (CD19 neg CD22 neg ) fractions was performed using a two-step magnetic bead cell sorting. First, CD19 pos B lymphocytes were obtained by positive selection using CD19 microbeads (StemCell Technologies, Vancouver, Canada). Residual B cells were then eliminated from the unbound fraction by a second round of depletion using CD22 microbeads (Miltenyi Biotec, Gladach, Germany), obtaining, therefore, the CD19 neg CD22 neg microenvironment compartment (Env 
RNA extraction
Total RNA was extracted using AllPrep ARN/ADN Mini Kit (Qiagen, Valencia, CA, USA), as recommended by the manufacturer, including DNAse I treatment. RNA purity and integrity was assessed by capillary electrophoresis using the Bioanalyzer 2100 (Agilent, Santa Clara, CA, USA) and the 2100 Expert software. All samples used for microarray studies displayed an RNA integrity number (RIN) of at least 6.7 (mean ¼ 9.2, range ¼ 6.7-10).
Microarray hybridization
Microarray analyses were performed either on CD19 pos fractions of 16 FLs (FL_B) and five non-malignant (NEG_B) LNs, or CD19 neg CD22 neg microenvironment fractions (eight FL_Env and six NEG_Env). Biotinylated complementary RNA were amplified according to the small sample labeling protocol and hybridized on the GeneChip HG-U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Santa Clara, CA, USA), according to the manufacturer's instruction. Data analyses were performed using the ArrayAssist software (Stratagene, La Jolla, CA, USA) (see Supplementary data).
Real-time quantitative PCR (RQ-PCR)
Microarray results were confirmed by RQ-PCR on a set of 19 FL_Env, eight NEG_Env and six CD19 neg CD22 neg fractions obtained from tonsils (TONS_Env). Reverse transcription was performed on 1 mg of total RNA using the Superscript II reverse transcriptase and random hexamers (Invitrogen, Carlsbad, CA, USA). On-demand gene expression assays and the TaqMan Universal master mix on an ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) were used for RQ-PCR. ABL was determined as the appropriate internal housekeeping gene. For each sample, the C t value for the gene of interest was determined, normalized to its respective value of ABL and compared to the value obtained for NEG_Env, using the DC t method. For IL4 messenger RNA (mRNA) expression, the median of FL_Env expression, evaluated by RQ-PCR, was 11.1 compared to NEG_Env (assigned to 1). We classified the FL cases according to IL4 low (IL4 lo o10) or high (IL4 hi 412) relative expression. Statistical analyses were performed with Prism software (GraphPad Software Inc., San Diego, CA, USA) using a Mann-Whitney non-parametric U-test (*Po0.05, **Po0.01 and ***Po0.001). In addition, GCET2/HGAL was explored on purified FL_B treated or not with IL-4 (R&D Systems, Minneapolis, MN, USA, 10 ng/ml), whereas IL4 was quantified on purified T FH versus Env non-T FH obtained from both tonsils and FL.
Immunohistochemistry
Tonsils (n ¼ 3), reactive LNs with follicular hyperplasia (n ¼ 7) and FL (n ¼ 12) biopsies were analyzed as previously described. 21 Briefly, after appropriate antigen retrieval with microwave heating in high pH Target Retrieval Solution (DakoCytomation, Glostrup, Denmark), deparaffinized tissue sections were stained with anti-P-STAT6/Tyr641 antibody (polyclonal rabbit; dilution 1/30; Cell Signaling Technology, Danvers, MA, USA), using an indirect immunoperoxidase method (ImmPRESS anti-rabbit; Vector Laboratories, Burlingame, CA, USA) and diaminobenzidine (Vector Laboratories) as chromogen. For double immunostaining, slides were first incubated with anti-CD20 (clone L26, Dako), anti-CD5 (clone 4C7, Novocastra, Newcastle, UK) or anti-PD1 (clone NAT, Abcam, Cambridge, UK) monoclonal antibody and labeled using the alkaline phosphatase-conjugated avidin biotinylated enzyme complex procedure (Vector Laboratories). Naphthol phosphate fast red was used as chromogen (Sigma, St Louis, MO, USA). Then, slides were incubated with anti-phospho-STAT6/Tyr641 and detected as described above. External positive controls included nodular sclerosis classical Hodgkin lymphomas and paraffin-embedded blocks of L428 Hodgkin lymphoma-derived and MedB1 primary mediastinal B cell lymphoma-derived cell lines. Images were captured with a Zeiss Axioskop2 microscope (Zeiss, Oberkochen, Germany) and Neofluar Â 100/0.1 NA optical lenses (Zeiss). Photographs were taken with a DP70 Olympus camera (Olympus, Tokyo, Japan). Image acquisition was performed with Olympus DP Controller 2002, and images were processed with Adobe Photoshop 7.0 (Adobe Systems, San Jose, CA, USA).
Results
Validation of our cell-sorting method
To validate our approach of cell separation, we analyzed, by flow cytometry, the different compartments before and after cell purification. Malignant B cells were evaluated on the basis of kappa/lambda staining on CD19 pos cells and, before cell sorting, represented more than 75% of the total cell count and 90% of B lymphocytes (median ¼ 96.5%; range ¼ 75-100). After the two-step purification, B cell purity was at least 92% of the CD19-sorted fractions (median ¼ 97%; range ¼ 92-100), whereas the non-B-cell fractions were contaminated by less than 12% of CD20 pos B cells (median ¼ 0.7%; range ¼ 0-12). To further explore our cell purification method, we demonstrated, using tonsils samples, the unbiased enrichment of T cell subsets (Supplementary Figure S1) Figure S1 ).
Microarray analysis of the FL-specific interface
We used a microarray approach to characterize gene expression patterns in different purified subpopulations of 16 FLs (16 FL_B and eight FL_Env) and six non-malignant (NEG) LNs (five NEG_B and six NEG_Env). These 35 samples were labeled and hybridized onto Affymetrix U133 Plus 2.0 oligonucleotide arrays. Raw data were normalized using GC-Robust Multiarray Averaging method and filtered to select probe sets (PSs) with s.d.-to-mean ratio higher than 80%. This method reduces the panel to 8779 PSs showing the highest expression variation. Unsupervised analyses of either B-cell compartments (n ¼ 21) or non-B cell compartments (n ¼ 14) allowed to differentiate FL from NEG samples ( Figure 1a ). To determine the gene expression pattern specific to each cell compartment implicated in the host-tumor cross talk, a step-wise statistical approach was conducted on the 35 samples by combining a Significance Analysis of Microarrays method and an asymptotic unpaired Mann-Whitney non-parametric test. On the basis of this approach, we defined four different PS lists (Figure 1b Table S3 ).
IL-4 is upregulated in FL and promotes malignant B cell activation
Within the 788-PS list defining the FL-specific interface, we identified, using Ingenuity pathway analysis, 26 FL-specific functional networks, including an IL-4-centered pathway, a cell growth and proliferation pathway and an immune response pathway (Supplementary Table S4 ). We pointed out that cell growth, T-lymphocyte proliferation and T-lymphocyte activation were altered in the FL microenvironment, with upregulation of BATF, IFNRAR2, TNFRSF9, TRAF1, CCL4, IL10, IL15, IL4, TNRFRSF4 or TNFRSF18 gene expression. In addition, a gene ontology (GO) analysis of the 788-PS list confirmed a statistically significant overrepresentation of genes involved in the biological processes of lymphocyte proliferation (GO ¼ 0042100, P ¼ 0.00066) or lymphocyte activation (GO ¼ 0046649, P ¼ 0.00016), especially T-cell activation (GO ¼ 0042110, P ¼ 0.00011). According to the Onto-Tools pathway impact analysis, IL4 was present in six out of the top 20 functional pathways relevant for the 788-PS list description. Moreover, we performed hierarchical clustering analysis based on the previously described immune response 1 and 2 signatures. 18 Interestingly, the immune-response 1 segregated the FL_Env from the NEG_Env, indicating a preferential T cell signature in the FL cases (Supplementary Figure S2) . To further explore the T cell implication in FL tumorigenesis and specifically through the IL-4-centered pathway, we first validated by RQ-PCR the overexpression of IL4 mRNA in FL_Env, compared with NEG_Env (Figure 2a) . Similarly, IL4 was expressed at a very low level in non-B cell fraction from inflamed benign tonsils. The result confirmed the recently described higher levels of IL-4 protein in FL compared with benign follicular hyperplasia. 22 In this previous study, activation of signal transducer and activator of transcription 6 (STAT6) was poorly detectable, probably due to the use of whole tissue lysates. Given that FL B cells, like normal GC-derived B cells, strongly expressed CD124, the IL-4 receptor alpha (Figure 2b) , we decided to investigate the expression of activated phospho-STAT6 in situ by immunohistochemistry in malignant versus normal B cells. In reactive tonsils and LNs (n ¼ 10), only exceptional single cells positive for P-STAT6 (1 or 2 per section in magnification Â200) (Figure 2c, panel 1) were observed.
These cells were located in the interfollicular area or in the mantle zone of follicles and were not observed within GC. In only one case of reactive LN, a cluster of P-STAT6 pos cells was observed in the paracortex. By contrast, a high number of P-STAT6 pos cells was evidenced in all FL cases with interpretable staining (n ¼ 10), and were mainly located within the neoplastic follicles. These P-STAT6 pos cells consisted of either multiple scattered cells or small aggregates with a tendency of distribution at the periphery of malignant follicles (Figure 2c , panels 2 and 3). Double staining revealed that the P-STAT6 pos cells were CD20 pos B lymphocytes (Figure 2c, insert in panel 3) . Notably, the level of STAT6 mRNA was not different between FL_B and NEG_B compartments (data not shown). As IL-13 was not overexpressed in FL non-B cell compartments (data not shown), this phosphorylation of STAT6 is more likely to result from IL-4 than from IL-13. The overexpression of IL-4 within FL microenvironment was thus associated to a strong activation of malignant B cells. In agreement, we observed that both IL4I1 and HOXC4, two previously described IL-4 target genes, 21, 23 belonged to the 886-PS FL_B list (Supplementary Figure S3A) . Similarly, GCET2/HGAL, another gene reported as induced by IL-4 in normal B cells and in some malignant B-cell lines, 24 was significantly upregulated in FL_B compartment (Supplementary Figure S3B) even if it was excluded from the microarray analysis by the initial standard deviation-based filtering. Interestingly, we demonstrated that GCET2/HGAL expression was also increased by IL-4 in purified primary B cells obtained from FL patients (Figure 2d ).
IL-4 is predominantly produced by FL-derived T FH
IL-4 is widely recognized as a Th2 cytokine in the periphery even if recent studies have suggested that, within reactive LNs, T FH are the main IL-4-secreting T cells, in agreement with the critical role of this cytokine for antibody production. 7, [25] [26] [27] To identify the IL-4-producing cells in FL context, we first compared The 'FL specific interface' defined the most relevant genes involved in the FL and microenvironment interface, represented by the probe sets that overlapped between FL-specific interface 1 and interface 2.
T FH -derived IL-4 in follicular lymphoma C Pangault et al by RQ-PCR, in the microenvironnement of FL versus nonmalignant samples, the expression of BCL6, GATA3 and TBX21/ TBET transcription factors, which are involved in the commitment to T FH , Th2 and Th1 differentiation, respectively. Both, the BCL6 expression and the GATA3/TBX21 ratio were increased in FL tumors, suggesting a simultaneous enrichment in T FH and Th2-polarized CD4 pos T cells. In addition, IL10, the second prototypic Th2 cytokine, was also overexpressed in FL_Env (Supplementary Figure S4A) . As T FH also express low levels of GATA3, 27 we decided to further explore the potential contribution of T FH to FL pathogenesis through the synthesis of IL-4. First, a gene set enrichment analysis approach was used to specifically assess the overrepresentation of previously described T FH genes within the FL microenvironment. Given the recent demonstration in both mice and human that CXCR5 and ICOS are the two most relevant T FH phenotypic markers, we defined our T FH signature based on the data sets previously published by Rasheed et T FH -derived IL-4 in follicular lymphoma C Pangault et al in genes specifically overexpressed in T FH cells (Po0.01 using both SNR-based ranking and FC-based ranking) (Supplementary Figure S4B) . Interestingly, when we performed an unsupervised hierarchical clustering restricted to the 226 PSs of the T FH signature belonging to our initial data set of 8879 PSs, we were able to segregate FL cases from non-tumoral tissues (data not shown), indicating that the T FH signature was sufficient by itself to distinguish the FL microenvironment from the non-malignant microenvironment. The cluster of coordinately regulated T FH -associated genes was underlined in Figure 1a . Moreover, unsupervised analysis based on T FH signature revealed the clustering of FL_Env according to their IL4 mRNA expression level (Figure 3) Figure S4C) . To take into account the inflammatory process that develops within FL microenvironment, we decided to explore also the non-B cell compartment obtained from chronically activated tonsils. In fact, substantial differences were seen in the degree of GC compartmentalization between human LN GC and human tonsil GC, including an accumulation of GC T cells in the latter one. 29 Interestingly, the level of expression of CXCL13, CXCR5 and PDCD1 in tonsil microenvironment, in similar extent than FL LNs, was also upregulated compared to normal LNs. We then quantified by flow cytometry the percentage of CD4 pos CD25 neg T cells coexpressing high levels of CXCR5 and ICOS T FH markers (Figure 4a ) and observed a significant expansion of the T FH cell compartment, in both FL tumors and tonsils compared to normal LN (Figure 4b) . Notably, the two reactive LNs with higher percentages of T FH corresponded to samples with a strong follicular hyperplasia. FL microenvironment is thus characterized, like samples with strong GC activation, by a high infiltration of T FH cells. Within FL biopsies, P-STAT6 pos B cells were observed in close contact with CD5 pos T cells and most of them were located at the vicinity of cells expressing the PD-1 T FH marker (Figure 4c ). Previously, it had been very difficult to identify IL-4-producing cells in situ 25 and T FH are highly susceptible to apoptosis in vitro. 28 To definitively determine the IL-4-producing cells, we thus decided to purify the T FH and the non-B non-T FH cell sub sets in FL and tonsils and to screen these cell compartments for IL4 mRNA. IL4 was highly produced by the T FH fraction issued from FL compared to the other non-malignant cells of the microenvironment, whereas tonsilderived T FH expressed a low but significant level of IL4 mRNA (Figure 4d ). In addition, when considering more specifically the non-T FH CD4 pos CXCR5 neg ICOS neg T-cell subset, we confirmed that T FH are the predominant IL4 producing CD4 pos T cells in FL (data not shown). Collectively, these results indicated that FL-infiltrating T FH specifically produced very high levels of IL-4.
Discussion
Follicular lymphoma represents a paradigm of microenvironment involvement in cancer behavior. Indeed, as previously described, the aggressiveness of the disease and the prognosis were carried by molecular features of non-malignant cells. 18 Various studies have demonstrated the potential for using gene expression profiles for the assessment of tumor-specific pathways. To further explore the cellular cross talk between lymphoma cells and their microenvironment, previous studies developed limited cell-sorting experiments. This approach allowed the purification of malignant and non-malignant subpopulations for the validation of some specific findings obtained by microarray on global tissues. 18 To characterize the FL cell niche and molecular features that sustain tumor B-cell growth within a specific microenvironment, we carried out an exhaustive gene profiling study based on a validated purification method separating systematically fresh tumor cell suspension into CD19 pos and CD19 neg CD22 neg compartments and we compared de novo FL to non-malignant LN.
Various gene lists were generated leading to the definition of the FL interface as the specific host-tumor interface, including an IL-4-centered signature. We were able to identify by microarray the overexpression of IL4 mRNA in FL, demonstrating the better sensitivity of our purification-based microarray approach compared to previous studies, ruling out the idea that for IL-4 no correlation may exist in FL between gene expression and protein levels. 23 Interestingly, although the size of our FL cohort and our study design did not allow the exploration of patient's prognosis in regard to gene profile, we observed that the immune-response 1 described by Dave et al. 18 could T FH -derived IL-4 in follicular lymphoma C Pangault et al segregate the FL from the non-malignant microenvironment, indicating a preferential T-cell signature among the FL cases. In addition, our FL specific interface showed a preferential expression of the CXCL13 chemokine in FL. Therefore, both findings together suggest that the FL microenvironment retain features of the GC light zone. 30 Whereas we detected, as previously described, 31 an upregulation of IL4R mRNA in purified FL cells compared with normal CD19 pos B cells T FH -derived IL-4 in follicular lymphoma C Pangault et al and CD19 pos CD10 pos GC B cells (data not shown), CD124 was similarly expressed at the cell surface in FL cells and tonsil-derived GC B cells, indicating that the major tumorassociated event in the IL-4 pathway lies in the microenvironment. We detected significant in vivo activation of STAT6 in malignant B cells in contrast to normal GC B cells, in agreement with a functional IL-4-dependent signaling. Strikingly, STAT6-associated signal has been associated with other B-cell malignancies. In primary mediastinal large B-cell lymphoma, STAT6 is constitutively activated in both cell lines and primary samples, 32 whereas Hodgkin Reed-Sternberg cells produce autocrine IL-13, resulting in STAT6 activation in classical Hodgkin lymphoma. 33 Whereas IL-4 overexpression was already described in whole FL biopsies, 22 we, to the best of our knowledge, show for the first time that a paracrine secretion of IL-4 by tumor microenvironment could be involved in lymphomagenesis. STAT6 is a critical signaling molecule for IL-4-mediated protection of spontaneous and Fas-induced cell death in mice primary B cells. 34 Few data are available on the direct effect of IL-4 on FL cells, 35 in particular due to the lack of appropriate cell lines. Nevertheless, STAT6 knockdown induces apoptosis in Hodgkin lymphoma cell lines 36 and IL-4 increases cell proliferation of GC-like diffuse large B cell lymphomas (DLBCL) through STAT6 phosphorylation. 24 A high proportion of genes overexpressed in FL B cells compared to normal CD19 pos B cells, including MME/CD10, BCL6 and MTA3, corresponded in fact to GC-associated genes (data not shown). However, our approach that compares purified FL cells, representing GC-derived neoplastic B cells, with normal B cells, including both GC-and non-GC-derived B cells, is a suboptimal approach to characterize specifically FL B-cell features. One could therefore hypothesize that, as the profiling of FL B cells showed important molecular features of normal GC B cells and given that FL could evolve into GC-like DLBCL, 37 the association of IL-4 overexpression and STAT6 activation could favor malignant B cell survival and proliferation. In addition, as previously described for GC-like DLBCL lines, IL-4 increased the expression of GCET2/HGAL in FL cells, and, given the role of HGAL in modulating GC B cell motility, 38 could thus contribute to the confinement of malignant B cells to the GC. Moreover, IL-4 drives macrophages toward a M2 phenotype endowed with immunoregulatory and proangiogenic properties, and several studies have indicated that tumors could cause recruited monocytes to exhibit an M2-like phenotype 39 potentially implicated in the adverse prognostic value of a high number of tumor-associated macrophages in FL. 13 Interestingly, the IL-4-specific target gene IL4I1 was recently found as specifically expressed by malignant B cells in GC-derived B-cell lymphomas including FL, whereas no expression was observed in tumor cells of T/NK neoplasms, mantle cell lymphomas or marginal zone lymphomas. 22 Moreover, a significant correlation (P ¼ 0.036) was observed between high IL4 mRNA expression and a low Follicular Lymphoma International Prognostic Index score. However, a large cohort will be necessary to explore the prognostic value of IL-4/IL-4 target gene overexpression in FL.
Besides IL-4, several other cytokines were observed to be overexpressed in FL_Env. In particular, we confirmed herein our previous results describing the induction of inflammatory cytokines, including TNF and IFNG, in FL microenvironment 40 in agreement with the former detection of these two factors in FL-invaded LN using in situ hybridization or PCR experiments. 41, 42 The reason for the discrepancy between these data and the study of Calvo et al. 22 that reported a decrease in tumor necrosis factor-a and interferon-g protein levels in FL whole biopsies is not clear. Of course, gene expression does not always correlate with protein expression; however, as elevated levels of circulating tumor necrosis factor-a have been observed in FL and DLBCL patients, 43 another possible explanation could be the higher sensitivity of our purification-based method. In agreement, both FASLG and GZMA belonged to the 897-PS gene list defining the FL microenvironment, suggesting an activated T-cell signature in this disease.
It has long been assumed that IL-4 is produced by the Th2 T-cell subset and promotes the Th2 polarization. In agreement with the overexpression of IL4 in FL microenvironment, we reported an increased GATA3/TBET ratio in this disease, a finding generally interpreted as a bias in the Th1/Th2 balance. This result fits well with previous data showing that the few tumor-reactive effector T cells within FL tumors display a Th2 functional profile after in vitro stimulation. 44 In addition, a mouse model of T-dependent lymphomagenesis has been recently developed in which repeated infusions of idiotypespecific Th2 cells support the development of B cell lymphoma, which could be conversely eradicated by Th1 cells. 45 Finally, we detected a significant upregulation of IL10 expression, another emblematic Th2 cytokine, within FL microenvironment. Interestingly, single nucleotide polymorphisms in the IL10 promoter were associated with increased risk for both DLBCL and FL. 46 However, the segregation of helper T cells into unique highly specialized subsets has been recently challenged by several studies, suggesting a common inductive history with intermediate stages exhibiting higher functional plasticity than previously believed. 47 Gene expression profiling and analyses of knockout mice models have first suggested that T FH cells constitute a separate Th cell lineage with distinct developmental programming and specific effector functions, like providing help to B cells for their differentiation into Ig-secreting cells. 48 In addition, recent findings suggest that T FH represent the normal counterpart of angioimmunoblastic T-cell lymphomas. 48, 49 Moreover, recent articles suggest that IL-4 secretion by lymphoid cells is highly related to T FH cells in mice after helminth infection and in human inflamed tonsils. [25] [26] [27] 48 We here demonstrate for the first time that chronically activated tumor-infiltrating CXCR5 hi ICOS hi T FH express high levels of IL-4 in FL, suggesting major therapeutic implications.
IL-4-dependent STAT6 activation was reported to modulate the behavior of another very important CD4 pos T cell subset, that is, regulatory T cells (Treg). However, whereas initial studies clearly demonstrated that STAT6 directly represses tumor necrosis factor-b1-mediated FOXP3 transcription and overrules inducible Treg differentiation, 50 exogenous IL-4 conversely maintains FOXP3 level in natural Treg and promotes their proliferation. 51 In agreement, we observed no correlation between the number of T FH and the number of Treg within FL LN (data not shown).
In summary, we propose a new sensitive and specific gene profiling approach allowing the identification of genes involved in the cross talk between malignant cells and their non-malignant microenvironment. Using this original and fully validated method, we revealed that FL microenvironment, along with P-STAT6-activated FL B cells, is characterized by a strong infiltration by T FH cells displaying a specific activation profile characterized by the expression of IL-4. These findings could be very useful to better understand lymphoma biology and to develop effective targeted therapies in this still incurable disease.
